| Particulars |
|
|
|
| Company Name
| Concord Biotech Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
10.46 |
B.V. (₹) |
173.30 |
| Sales(₹ Cr.) |
1,200.09 |
NP (₹ Cr.) |
372.96 |
| NP Var% |
27.00 |
Div% |
1,070.00 |
| CPS(₹) |
40.80 |
EPS (₹) |
35.70 |
| Traded Value(₹ Lakhs) |
213.77 |
52 Week High |
2,658.00 |
| 52 Week Low |
1,370.00 |
Price BSE |
1,840.00 |
| Price NSE |
1,837.00 |
Market Capital (₹ Cr.) |
19,249.90 |
| P/C Ratio |
45.00 |
P/E Ratio |
51.60 |
| Price Vs.BV |
10.62 |
|
| Latest Quarter |
| Year End |
202503 |
Sales (₹ Cr.) |
429.88 |
| NP(₹ Cr.) |
141.94 |
NP Var % |
46.00 |
| Trailing Twelve Months |
| Year End |
202503 |
Sales |
1,085.75 |
| OPM |
42.20 |
NP |
328.71 |
| NP Var% |
26.75 |
EPS |
35.65 |
| PE |
51.61 |
|
|